Comparison of bromfenac 0.09 QD to nepafenac 0.1 TID after cataract surgery: pilot evaluation of visual acuity macular volume and retinal thickness at a single site

摘要

PurposeThe purpose of this study was to investigate the clinical outcomes of bromfenac ophthalmic solution 0.09% once daily (QD) and nepafenac 0.1% ophthalmic suspension three times daily following cataract extraction with posterior chamber intraocular lens implantation, specifically looking at any differences in Early Treatment Diabetic Retinopathy Study visual acuities, macular volume, and/or retinal thickness changes.